A researcher team is collaborating with a Belgian industry partner to develop an antibody-based rapid VRE test capable of reliably detecting the expression of VanA and VanB. Enterococcus faecium is a ...
Vedanta Biosciences is a late clinical-stage biopharmaceutical company developing a new category of microbiome-based oral therapies for gastrointestinal diseases. Vedanta's lead program, VE303, is ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult‑to‑treat bacterial ...
Three Consecutive Years of Ongoing Predictable Media™ Partnership NEW YORK CITY, NY / ACCESS Newswire / April 7, 2026 / ...
MRSA colonization was found to be associated with an increased risk of infection (adjusted odds ratio [OR] 15.64; 95% CI 6.63–36.89), and the risk of death was approximately twofold higher in patients ...
The advent of modern antibiotics contributed enormously to the dramatic extension of human lifespan since their discovery by virtue of their lethal and selective action against pathogenic microbes.
Some types of starch, called resistant starch, are resistant to digestion. Examples include oats, rice, green bananas, beans, and legumes. How food is prepared can affect resistant starch. For example ...